Postoperative Radiotherapy in the Management of Resected Non-Small-Cell Lung Carcinoma: 10 Years' Experience in a Single Institute

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 433-439

  Karakoyun Celik, Omur ^a   Yalman, Deniz ^b   Bolukbasi, Yasemin ^b   Cakan, Alpaslan ^b   Cok, Gursel ^b   Ozkok, Serdar ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adjuvant radiotherapy; Postoperative radiotherapy; Resected non small cell lung cancer

Indexed keywords

ADJUVANT RADIOTHERAPY; ADJUVANT TREATMENT; DEATH RATES; DISTANT METASTASIS; KAPLAN-MEIER ESTIMATES; LATERALIZATION; LOCOREGIONAL CONTROL; LONG-TERM OUTCOME; LUNG CARCINOMA; LYMPH NODE; MEDIAN SURVIVAL; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PERFORMANCE STATUS; POSTOPERATIVE RADIOTHERAPY; PROGNOSTIC FACTORS; RADIATION-INDUCED; SURGICAL PROCEDURES; SURVIVAL RATE;

BIOLOGICAL ORGANS; PATHOLOGY; TUMORS;

RADIOTHERAPY;

CISPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COBALT THERAPY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LIVER METASTASIS; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG FIBROSIS; LUNG INFECTION; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHOTON THERAPY; PNEUMONIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COBALT RADIOISOTOPES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 73649089303     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.010     Document Type: Article

References (41)

1. Sawyer T.E., Bonner J.A., Gould P.M., et al. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 80 (1997) 1399-1408
2. Emami B., Kaiser L., Simpson J., et al. Postoperative radiation therapy in non-small cell lung cancer. Am J Clin Oncol 20 (1997) 441-448
3. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 315 (1986) 1377-1381
4. Feng Q.F., Wang M., Wang L.J., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: A randomized trial. Int J Radiat Oncol Biol Phys 47 (2000) 925-929
5. Mayer R., Smolle-Juettner F.M., Szolar D., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 112 (1997) 954-959
6. Stephens R.J., Girling D.J., Bleehen N.M., et al. The role of post-operative radiotherapy in non-small-cell lung cancer: A multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Br J Cancer 74 (1996) 632-639
7. Choi N.C., Grillo H.C., Gardiello M., et al. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 6 (1980) 31-35
8. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 25 352 (1998) 257-263
9. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
10. Feld R., Feld R., Rubinstein L.V., et al. Sites of recurrence in resected stage I non-small-cell lung cancer: A guide for future studies. J Clin Oncol 2 (1984) 1352-1358
11. Pairolero P.C., Williams D.E., Bergstralh E.J., et al. Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease. Ann Thorac Surg 38 (1984) 331-338
12. Thomas P., and Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 49 (1990) 242-246
13. Munro A.J. What now for postoperative radiotherapy for lung cancer?. Lancet 352 (1998) 250-251
14. Trodella L., Granone P., Valente S., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: Definitive results of a phase III randomized trial. Radiother Oncol 62 (2002) 11-19
15. Granone P., Keller S., Trodella L., et al. Postoperative radiotherapy in completely resected, early-stage NSCLC: Reflections and future directions. Lancet Oncol 3 (2002) 589-590 discussion 590-591
16. Lally B.E., Detterbeck F.C., Geiger A.M., et al. The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: Analysis of the Surveillance, Epidemiology, and End Results database. Cancer 110 (2007) 911-917
17. Wakelee H.A., Stephenson P., Keller S.M., et al. Eastern Cooperative Oncology Group. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Lung Cancer 48 (2005) 389-397
18. Machtay M., Lee J.H., Shrager J.B., et al. Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non-Small-Cell Lung Carcinoma. J Clin Oncol 19 (2001) 3912-3917
19. Sawyer T.E., Bonner J.A., Gould P.M., et al. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks. Ann Thorac Surg 64 (1997) 1402-1407 discussion 1407-1408
20. Douillard J.Y., Rosell R., De Lena M., et al. Adjuvant Navelbine International Trialist Association. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) randomized trial. Int J Radiat Oncol Biol Phys 72 (2008) 695-701
21. Park J.H., Shim Y.M., Baek H.J., et al. Postoperative adjuvant therapy for stage II non-small-cell lung cancer. Ann Thorac Surg 68 (1999) 1821-1826
22. Lally B.E., Zelterman D., Colasanto J.M., et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the Surveillance, Epidemiology, and End Results Database. J Clin Oncol 24 (2006) 2998-3006
23. Jazieh A.R., Hussain M., Howington J.A., et al. Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg 70 (2000) 1168-1171
24. Caro J.J., Salas M., Ward A., et al. Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review. Cancer 91 (2001) 2214-2221
25. Doddoli C., Barlesi F., Trousse D., et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: An uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 130 (2005) 416-425
26. Ferguson M.K., and Lehman A.G. Sleeve lobectomy or pneumonectomy: Optimal management strategy using decision analysis techniques. Ann Thorac Surg 76 (2003) 1782-1788
27. Darling G.E., Abdurahman A., Yi Q.L., et al. Risk of a right pneumonectomy: Role of bronchopleural fistula. Ann Thorac Surg 79 (2005) 433-437
28. Kawaguchi T., Tojo T., Kushibe K., et al. Short- and long-term outcomes after pneumonectomy for primary lung cancer. Ann Thorac Cardiovasc Surg 14 (2008) 289-293
29. Ramnath N., Demmy T.L., Antun A., et al. Pneumonectomy for bronchogenic carcinoma: Analysis of factors predicting survival. Ann Thorac Surg 83 (2007) 1831-1836
30. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
31. Kaiser L.R., Fleshner P., Keller S., et al. Significance of extramucosal residual tumor at the bronchial resection margin. Ann Thorac Surg 47 (1989) 265-269
32. Soorae A.S., and Stevenson H.M. Survival with residual tumor on the bronchial margin after resection for bronchogenic carcinoma. J Thorac Cardiovasc Surg 78 (1979) 175-180
33. Kimura H., and Yamaguchi Y. Survival of noncuratively resected lung cancer. Lung Cancer 11 (1994) 229-242
34. Downey R.J., Martini N., Rusch V.W., et al. Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg 68 (1999) 188-193
35. Hofmann H.S., Taege C., Lautenschläger C., et al. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardiothorac Surg 21 (2002) 606-610
36. Snijder R.J., Brutel de la Rivière A., Elbers H.J., et al. Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. Ann Thorac Surg 65 (1998) 212-216
37. Liewald F., Hatz R.A., Dienemann H., et al. Importance of microscopic residual disease at the bronchial margin after resection for non-small-cell carcinoma of the lung. J Thorac Cardiovasc Surg 104 (1992) 408-412
38. Ginsberg R.J., and Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60 (1995) 615-622
39. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
40. Miller D.L., Rowland C.M., Deschamps C., et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 73 (2002) 1545-1550
41. Kaneda M., Watanabe F., Tarukawa T., et al. Limited operation for lung cancer in combination with postoperative radiation therapy. Ann Thorac Cardiovasc Surg 13 (2007) 15-20